Q & A: What you need to know about new Alzheimer’s drug ( www.eastbaytimes.com )
This week the U.S. Food and Drug Administration approved the drug lecanemab after research showed it slowed the progression of Alzheimer’s disease in some patients with mild cognitive impairment....
![](https://kbin.cafe/media/cache/resolve/entry_thumb/96/16/9616d1b237319ee6c3f2a31d20bb5c82e72dd1e675d169ee398f87690dfea90f.jpg)